.jpg&w=3840&q=100)
1. What is the projected Compound Annual Growth Rate (CAGR) of the Diabetes Care Devices Market?
The projected CAGR is approximately 10%.
Market
Insights
7,500+
Reports delivered globally, covering a wide range of industries and sectors.
2,350+
Clients who trust our expertise and rely on our insights for business decisions.
1,050+
Managed Reports, ensuring seamless updates and premium service.
100%
Satisfied Customers, committed to delivering exceptional value and quality.
Diabetes Care Devices Market Report Probes the 46.1 Billion Size, Share, Growth Report and Future Analysis by 2033
Diabetes Care Devices Market by Product (Blood glucose monitoring devices, Insulin delivery devices), by End-use (Hospital, Ambulatory surgical centers, Diagnostic centers, Homecare, Other end-users), by North America (U.S., Canada), by Europe (Germany, UK, France, Netherlands, Sweden, Belgium, Denmark, Finland, Norway, Lithuania, Latvia, Estonia, Rest of Europe), by Asia Pacific (Japan, China, India, Australia, South Korea, Rest of Asia Pacific), by Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru, Rest of Latin America), by Middle East and Africa (South Africa, Saudi Arabia, UAE, Turkey, Egypt, Israel, Kuwait, Qatar, Rest of Middle East and Africa) Forecast 2025-2033
Diabetes Care Devices Market Report Probes the 46.1 Billion Size, Share, Growth Report and Future Analysis by 2033
Key Insights
The global Diabetes Care Devices market is experiencing robust growth, projected to reach a value of $46.1 billion in 2025 and maintain a Compound Annual Growth Rate (CAGR) of 10% from 2025 to 2033. This expansion is fueled by several key factors. The rising prevalence of diabetes worldwide, particularly type 2 diabetes, is a primary driver. Aging populations in developed nations and increasing urbanization in developing countries contribute significantly to this epidemiological shift. Furthermore, advancements in diabetes care technology, including the development of more accurate, user-friendly, and minimally invasive devices like continuous glucose monitors (CGMs) and insulin pumps with improved safety features, are significantly impacting market growth. Increased awareness of diabetes management and the availability of better healthcare infrastructure also play crucial roles. While the high cost of advanced devices and the need for consistent medical monitoring represent market restraints, these are being counterbalanced by technological innovation and increasing insurance coverage in several regions. The market is segmented by product type (blood glucose monitoring devices, insulin delivery devices), and end-user (hospitals, ambulatory surgical centers, diagnostic centers, homecare). The homecare segment is expected to witness particularly strong growth due to the rising preference for self-monitoring and improved device portability. Major players like Abbott Laboratories, Dexcom, Medtronic, and Novo Nordisk are driving innovation and market penetration through research and development, strategic partnerships, and aggressive marketing campaigns. Geographic distribution shows North America and Europe currently holding the largest market share, reflecting established healthcare systems and higher per capita disposable incomes. However, the Asia Pacific region is expected to experience substantial growth over the forecast period, driven by its expanding diabetic population and rising healthcare expenditure.
The competitive landscape is characterized by both established multinational corporations and emerging players focusing on specialized technologies. Competition is fierce, driven by continuous product innovation, the need to secure favorable insurance reimbursement rates, and expanding global reach. The focus is increasingly shifting towards personalized diabetes management solutions, integrating data analytics and remote monitoring capabilities to improve patient outcomes. The market's future growth trajectory will depend on factors such as continued technological advancements, government initiatives to improve diabetes care access, and the evolving healthcare policies within different regions. Further research into more effective and less invasive treatment options will further propel market growth in the long term.
Diabetes Care Devices Market Concentration & Characteristics
The global diabetes care devices market is moderately concentrated, with several large multinational corporations holding significant market share. However, the market also features a substantial number of smaller players, particularly in the areas of specialized devices and niche technologies. This dynamic fosters both intense competition and opportunities for innovation.
Concentration Areas:
- Continuous Glucose Monitoring (CGM): This segment exhibits high concentration, dominated by a few key players with established technologies and extensive distribution networks.
- Insulin Delivery Systems: This area is also relatively concentrated, characterized by significant competition among established pharmaceutical and medical device companies.
- Blood Glucose Meters (BGM): While seemingly fragmented at first glance, there's a higher level of concentration among the leading brands enjoying significant brand recognition and market reach.
Characteristics:
- Rapid Innovation: The market is marked by continuous technological advancements, driven by the need for improved accuracy, convenience, and integration with other healthcare technologies.
- Regulatory Impact: Stringent regulatory approvals (e.g., FDA, CE Mark) are crucial for market entry and influence product development cycles and strategies. This creates a barrier to entry for smaller companies.
- Product Substitutes: While no perfect substitute exists for managing diabetes, alternative therapies and lifestyle modifications are always impacting the demand for specific devices.
- End-User Concentration: The market's end-users are diverse, ranging from hospitals and clinics to home-use settings. This creates varying demands regarding device features, pricing, and reimbursement models.
- M&A Activity: The market witnesses moderate merger and acquisition activity, with larger companies strategically acquiring smaller innovators to expand their product portfolios and technologies.
Diabetes Care Devices Market Trends
The diabetes care devices market is experiencing significant transformation, driven by several key trends:
Growing Prevalence of Diabetes: The global surge in diabetes cases, particularly Type 2 diabetes, fuels demand for more effective and user-friendly monitoring and management devices. This drives market expansion across all segments.
Technological Advancements: Continuous innovations in sensor technology, data analytics, and connectivity are leading to the development of sophisticated devices with enhanced accuracy, portability, and integration with smart devices and cloud platforms. CGMs are at the forefront of this trend, integrating seamlessly with smartphones and offering real-time data insights.
Increased Focus on Remote Monitoring: The increasing adoption of telehealth and remote patient monitoring (RPM) creates significant opportunities for connected devices that enable healthcare professionals to monitor patient data remotely. This improves patient care and reduces hospital readmissions.
Rise of Artificial Intelligence (AI): AI algorithms are being integrated into diabetes management devices to improve accuracy, provide personalized insights, and automate certain aspects of treatment. AI-powered predictive analytics is enabling proactive interventions, leading to better patient outcomes.
Growing Demand for Affordable Devices: The need for affordable diabetes care devices, especially in developing countries, is driving innovation and development of cost-effective solutions. This segment will require creative business models and partnerships to be truly successful.
Emphasis on Patient Empowerment: There is an increasing shift towards patient empowerment, with devices providing more control and self-management capabilities. This leads to preference for user-friendly interfaces and comprehensive data visualization tools.
Integration with Wearable Technology: The integration of diabetes management devices with wearable technology, such as smartwatches and fitness trackers, is expanding the possibilities of continuous monitoring and data integration. This is enhancing adherence to treatment plans.
Key Region or Country & Segment to Dominate the Market
The North American region currently dominates the diabetes care devices market, driven by high prevalence of diabetes, robust healthcare infrastructure, and high adoption of advanced technologies. Within this region, the United States is the largest market. However, growth is also projected to be significant in Asia Pacific and Europe.
Dominating Segments:
Continuous Glucose Monitors (CGMs): CGMs are experiencing the fastest growth rate due to their accuracy, convenience, and ability to reduce the burden of multiple finger-prick testing. This is driving significant market expansion and attracting substantial investment.
Insulin Delivery Devices: While standard insulin delivery devices maintain a significant market share, the increasing demand for safety features and improved convenience is driving growth in the safety insulin delivery device segment. This includes newer, easier-to-use devices and automated systems.
Homecare Setting: The majority of diabetes management takes place at home, making homecare the dominant end-use segment. This reinforces the market trends towards convenient, user-friendly and integrated devices suitable for self-management.
Diabetes Care Devices Market Product Insights Report Coverage & Deliverables
This report provides detailed insights into the diabetes care devices market, covering key product segments, including self-monitoring blood glucose meters, continuous glucose monitors, insulin delivery devices (both standard and safety types), lancets, and testing strips. The report analyzes market size, growth trends, competitive landscape, and future prospects for each product category, providing a comprehensive understanding of the market dynamics.
Diabetes Care Devices Market Analysis
The global diabetes care devices market is estimated to be valued at approximately $35 billion in 2023. This market is expected to experience a compound annual growth rate (CAGR) of around 7% between 2023 and 2028, reaching an estimated $50 billion by 2028. This growth is largely fueled by the increasing prevalence of diabetes worldwide and the continuous development of innovative devices with improved features and accuracy.
Market share is currently fragmented across several key players, with the top five companies accounting for roughly 40% of the market. However, the market is highly competitive, with many players vying for market share through product differentiation, technological advancements, and strategic partnerships.
Diabetes Care Devices Market Regional Insights
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Netherlands
- Sweden
- Belgium
- Denmark
- Finland
- Norway
- Lithuania
- Latvia
- Estonia
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Peru
- Rest of Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- Turkey
- Egypt
- Israel
- Kuwait
- Qatar
- Rest of Middle East and Africa
Each region exhibits unique market characteristics influenced by factors like diabetes prevalence, healthcare infrastructure, regulatory environment, and purchasing power.
Driving Forces: What's Propelling the Diabetes Care Devices Market
The market is primarily propelled by the increasing prevalence of diabetes globally, advancements in technology leading to improved device accuracy and convenience, rising demand for home-based monitoring, and the growing adoption of telehealth and remote patient monitoring solutions. Government initiatives and rising healthcare expenditure also contribute significantly.
Challenges and Restraints in Diabetes Care Devices Market
Challenges include high device costs, the need for continuous calibration and maintenance, the potential for device malfunctions, and the complexities of reimbursement systems. Competition from generic products and the need for ongoing technological innovation also pose ongoing challenges.
Emerging Trends in Diabetes Care Devices Market
Key emerging trends include the integration of artificial intelligence (AI) for personalized data analysis and predictive analytics, the development of miniaturized and wearable devices, greater focus on closed-loop insulin delivery systems, and increased adoption of cloud-based data management platforms for improved patient care coordination.
Diabetes Care Devices Industry News
- June 2022: Ascensia Diabetes Care received CE Mark approval for its Eversense E3 Continuous Glucose Monitoring (CGM) System.
- June 2022: Abbott announced the launch of a biowearable for continuous blood glucose and ketone monitoring.
- May 2022: ARKRAY, Inc., partnered with Rimidi to integrate its GLUCOCARD Shine Connex system with the Rimidi Platform.
Leading Players in the Diabetes Care Devices Market
- Abbott Laboratories
- Arkray, Inc.
- Ascensia Diabetes Care Holding AG
- B. Braun Melsungen AG
- Becton Dickinson and Company
- Bionime Corporation
- DarioHealth Corp.
- Dexcom, Inc.
- Dr. Reddy's Laboratories
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- Insulet Corporation
- LifeScan, Inc.
- Medtronic plc
- Nova Biomedical, Inc.
- Novo Nordisk A/S
- Pendiq GmBH
- Sanofi
- Sinocare, Inc.
- Tandem Diabetes Care Inc.
- Ypsomed AG
Diabetes Care Devices Market Segmentation
-
1. Product
-
1.1. Blood glucose monitoring devices
- 1.1.1. Self-monitoring blood glucose meters
- 1.1.2. Continuous glucose monitors
- 1.1.3. Testing strips
- 1.1.4. Lancets
-
1.2. Insulin delivery devices
- 1.2.1. Standard
- 1.2.2. Safety
-
1.1. Blood glucose monitoring devices
-
2. End-use
- 2.1. Hospital
- 2.2. Ambulatory surgical centers
- 2.3. Diagnostic centers
- 2.4. Homecare
- 2.5. Other end-users
Diabetes Care Devices Market Segmentation By Geography
-
1. North America
- 1.1. U.S.
- 1.2. Canada
-
2. Europe
- 2.1. Germany
- 2.2. UK
- 2.3. France
- 2.4. Netherlands
- 2.5. Sweden
- 2.6. Belgium
- 2.7. Denmark
- 2.8. Finland
- 2.9. Norway
- 2.10. Lithuania
- 2.11. Latvia
- 2.12. Estonia
- 2.13. Rest of Europe
-
3. Asia Pacific
- 3.1. Japan
- 3.2. China
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Latin America
- 4.1. Brazil
- 4.2. Mexico
- 4.3. Argentina
- 4.4. Colombia
- 4.5. Chile
- 4.6. Peru
- 4.7. Rest of Latin America
-
5. Middle East and Africa
- 5.1. South Africa
- 5.2. Saudi Arabia
- 5.3. UAE
- 5.4. Turkey
- 5.5. Egypt
- 5.6. Israel
- 5.7. Kuwait
- 5.8. Qatar
- 5.9. Rest of Middle East and Africa
Diabetes Care Devices Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 10% from 2019-2033 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1 Growing prevalence of diabetes across the world
- 3.2.2 Rising technological advancements in diabetes care devices
- 3.2.3 Increasing investments by public and private organizations for diabetes care
- 3.3. Market Restrains
- 3.3.1 High cost of diabetes care devices
- 3.3.2 Rigorous regulatory framework
- 3.4. Market Trends
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Product
- 5.1.1. Blood glucose monitoring devices
- 5.1.1.1. Self-monitoring blood glucose meters
- 5.1.1.2. Continuous glucose monitors
- 5.1.1.3. Testing strips
- 5.1.1.4. Lancets
- 5.1.2. Insulin delivery devices
- 5.1.2.1. Standard
- 5.1.2.2. Safety
- 5.1.1. Blood glucose monitoring devices
- 5.2. Market Analysis, Insights and Forecast - by End-use
- 5.2.1. Hospital
- 5.2.2. Ambulatory surgical centers
- 5.2.3. Diagnostic centers
- 5.2.4. Homecare
- 5.2.5. Other end-users
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. Latin America
- 5.3.5. Middle East and Africa
- 5.1. Market Analysis, Insights and Forecast - by Product
- 6. North America Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Product
- 6.1.1. Blood glucose monitoring devices
- 6.1.1.1. Self-monitoring blood glucose meters
- 6.1.1.2. Continuous glucose monitors
- 6.1.1.3. Testing strips
- 6.1.1.4. Lancets
- 6.1.2. Insulin delivery devices
- 6.1.2.1. Standard
- 6.1.2.2. Safety
- 6.1.1. Blood glucose monitoring devices
- 6.2. Market Analysis, Insights and Forecast - by End-use
- 6.2.1. Hospital
- 6.2.2. Ambulatory surgical centers
- 6.2.3. Diagnostic centers
- 6.2.4. Homecare
- 6.2.5. Other end-users
- 6.1. Market Analysis, Insights and Forecast - by Product
- 7. Europe Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Product
- 7.1.1. Blood glucose monitoring devices
- 7.1.1.1. Self-monitoring blood glucose meters
- 7.1.1.2. Continuous glucose monitors
- 7.1.1.3. Testing strips
- 7.1.1.4. Lancets
- 7.1.2. Insulin delivery devices
- 7.1.2.1. Standard
- 7.1.2.2. Safety
- 7.1.1. Blood glucose monitoring devices
- 7.2. Market Analysis, Insights and Forecast - by End-use
- 7.2.1. Hospital
- 7.2.2. Ambulatory surgical centers
- 7.2.3. Diagnostic centers
- 7.2.4. Homecare
- 7.2.5. Other end-users
- 7.1. Market Analysis, Insights and Forecast - by Product
- 8. Asia Pacific Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Product
- 8.1.1. Blood glucose monitoring devices
- 8.1.1.1. Self-monitoring blood glucose meters
- 8.1.1.2. Continuous glucose monitors
- 8.1.1.3. Testing strips
- 8.1.1.4. Lancets
- 8.1.2. Insulin delivery devices
- 8.1.2.1. Standard
- 8.1.2.2. Safety
- 8.1.1. Blood glucose monitoring devices
- 8.2. Market Analysis, Insights and Forecast - by End-use
- 8.2.1. Hospital
- 8.2.2. Ambulatory surgical centers
- 8.2.3. Diagnostic centers
- 8.2.4. Homecare
- 8.2.5. Other end-users
- 8.1. Market Analysis, Insights and Forecast - by Product
- 9. Latin America Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Product
- 9.1.1. Blood glucose monitoring devices
- 9.1.1.1. Self-monitoring blood glucose meters
- 9.1.1.2. Continuous glucose monitors
- 9.1.1.3. Testing strips
- 9.1.1.4. Lancets
- 9.1.2. Insulin delivery devices
- 9.1.2.1. Standard
- 9.1.2.2. Safety
- 9.1.1. Blood glucose monitoring devices
- 9.2. Market Analysis, Insights and Forecast - by End-use
- 9.2.1. Hospital
- 9.2.2. Ambulatory surgical centers
- 9.2.3. Diagnostic centers
- 9.2.4. Homecare
- 9.2.5. Other end-users
- 9.1. Market Analysis, Insights and Forecast - by Product
- 10. Middle East and Africa Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Product
- 10.1.1. Blood glucose monitoring devices
- 10.1.1.1. Self-monitoring blood glucose meters
- 10.1.1.2. Continuous glucose monitors
- 10.1.1.3. Testing strips
- 10.1.1.4. Lancets
- 10.1.2. Insulin delivery devices
- 10.1.2.1. Standard
- 10.1.2.2. Safety
- 10.1.1. Blood glucose monitoring devices
- 10.2. Market Analysis, Insights and Forecast - by End-use
- 10.2.1. Hospital
- 10.2.2. Ambulatory surgical centers
- 10.2.3. Diagnostic centers
- 10.2.4. Homecare
- 10.2.5. Other end-users
- 10.1. Market Analysis, Insights and Forecast - by Product
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2024
- 11.2. Company Profiles
- 11.2.1 Abbott Laboratories
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Arkray Inc.
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Ascensia Diabetes Care Holding AG
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 B. Braun Melsungen AG
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Becton Dickinson and Company
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Bionime Corporation
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 DarioHealth Corp.
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Dexcom Inc.
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 Dr. Reddy's Laboratories
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Eli Lilly and Company
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 F. Hoffmann-La Roche AG
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.12 Insulet Corporation
- 11.2.12.1. Overview
- 11.2.12.2. Products
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Financials (Based on Availability)
- 11.2.13 LifeScan Inc.
- 11.2.13.1. Overview
- 11.2.13.2. Products
- 11.2.13.3. SWOT Analysis
- 11.2.13.4. Recent Developments
- 11.2.13.5. Financials (Based on Availability)
- 11.2.14 Medtronic plc
- 11.2.14.1. Overview
- 11.2.14.2. Products
- 11.2.14.3. SWOT Analysis
- 11.2.14.4. Recent Developments
- 11.2.14.5. Financials (Based on Availability)
- 11.2.15 Nova Biomedical Inc.
- 11.2.15.1. Overview
- 11.2.15.2. Products
- 11.2.15.3. SWOT Analysis
- 11.2.15.4. Recent Developments
- 11.2.15.5. Financials (Based on Availability)
- 11.2.16 Novo Nordisk A/S
- 11.2.16.1. Overview
- 11.2.16.2. Products
- 11.2.16.3. SWOT Analysis
- 11.2.16.4. Recent Developments
- 11.2.16.5. Financials (Based on Availability)
- 11.2.17 Pendiq GmBH
- 11.2.17.1. Overview
- 11.2.17.2. Products
- 11.2.17.3. SWOT Analysis
- 11.2.17.4. Recent Developments
- 11.2.17.5. Financials (Based on Availability)
- 11.2.18 Sanofi
- 11.2.18.1. Overview
- 11.2.18.2. Products
- 11.2.18.3. SWOT Analysis
- 11.2.18.4. Recent Developments
- 11.2.18.5. Financials (Based on Availability)
- 11.2.19 Sinocare Inc.
- 11.2.19.1. Overview
- 11.2.19.2. Products
- 11.2.19.3. SWOT Analysis
- 11.2.19.4. Recent Developments
- 11.2.19.5. Financials (Based on Availability)
- 11.2.20 Tandem Diabetes Care Inc.
- 11.2.20.1. Overview
- 11.2.20.2. Products
- 11.2.20.3. SWOT Analysis
- 11.2.20.4. Recent Developments
- 11.2.20.5. Financials (Based on Availability)
- 11.2.21 Ypsomed AG
- 11.2.21.1. Overview
- 11.2.21.2. Products
- 11.2.21.3. SWOT Analysis
- 11.2.21.4. Recent Developments
- 11.2.21.5. Financials (Based on Availability)
- 11.2.1 Abbott Laboratories
List of Figures
- Figure 1: Global Diabetes Care Devices Market Revenue Breakdown (Billion, %) by Region 2024 & 2032
- Figure 2: North America Diabetes Care Devices Market Revenue (Billion), by Product 2024 & 2032
- Figure 3: North America Diabetes Care Devices Market Revenue Share (%), by Product 2024 & 2032
- Figure 4: North America Diabetes Care Devices Market Revenue (Billion), by End-use 2024 & 2032
- Figure 5: North America Diabetes Care Devices Market Revenue Share (%), by End-use 2024 & 2032
- Figure 6: North America Diabetes Care Devices Market Revenue (Billion), by Country 2024 & 2032
- Figure 7: North America Diabetes Care Devices Market Revenue Share (%), by Country 2024 & 2032
- Figure 8: Europe Diabetes Care Devices Market Revenue (Billion), by Product 2024 & 2032
- Figure 9: Europe Diabetes Care Devices Market Revenue Share (%), by Product 2024 & 2032
- Figure 10: Europe Diabetes Care Devices Market Revenue (Billion), by End-use 2024 & 2032
- Figure 11: Europe Diabetes Care Devices Market Revenue Share (%), by End-use 2024 & 2032
- Figure 12: Europe Diabetes Care Devices Market Revenue (Billion), by Country 2024 & 2032
- Figure 13: Europe Diabetes Care Devices Market Revenue Share (%), by Country 2024 & 2032
- Figure 14: Asia Pacific Diabetes Care Devices Market Revenue (Billion), by Product 2024 & 2032
- Figure 15: Asia Pacific Diabetes Care Devices Market Revenue Share (%), by Product 2024 & 2032
- Figure 16: Asia Pacific Diabetes Care Devices Market Revenue (Billion), by End-use 2024 & 2032
- Figure 17: Asia Pacific Diabetes Care Devices Market Revenue Share (%), by End-use 2024 & 2032
- Figure 18: Asia Pacific Diabetes Care Devices Market Revenue (Billion), by Country 2024 & 2032
- Figure 19: Asia Pacific Diabetes Care Devices Market Revenue Share (%), by Country 2024 & 2032
- Figure 20: Latin America Diabetes Care Devices Market Revenue (Billion), by Product 2024 & 2032
- Figure 21: Latin America Diabetes Care Devices Market Revenue Share (%), by Product 2024 & 2032
- Figure 22: Latin America Diabetes Care Devices Market Revenue (Billion), by End-use 2024 & 2032
- Figure 23: Latin America Diabetes Care Devices Market Revenue Share (%), by End-use 2024 & 2032
- Figure 24: Latin America Diabetes Care Devices Market Revenue (Billion), by Country 2024 & 2032
- Figure 25: Latin America Diabetes Care Devices Market Revenue Share (%), by Country 2024 & 2032
- Figure 26: Middle East and Africa Diabetes Care Devices Market Revenue (Billion), by Product 2024 & 2032
- Figure 27: Middle East and Africa Diabetes Care Devices Market Revenue Share (%), by Product 2024 & 2032
- Figure 28: Middle East and Africa Diabetes Care Devices Market Revenue (Billion), by End-use 2024 & 2032
- Figure 29: Middle East and Africa Diabetes Care Devices Market Revenue Share (%), by End-use 2024 & 2032
- Figure 30: Middle East and Africa Diabetes Care Devices Market Revenue (Billion), by Country 2024 & 2032
- Figure 31: Middle East and Africa Diabetes Care Devices Market Revenue Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global Diabetes Care Devices Market Revenue Billion Forecast, by Region 2019 & 2032
- Table 2: Global Diabetes Care Devices Market Revenue Billion Forecast, by Product 2019 & 2032
- Table 3: Global Diabetes Care Devices Market Revenue Billion Forecast, by End-use 2019 & 2032
- Table 4: Global Diabetes Care Devices Market Revenue Billion Forecast, by Region 2019 & 2032
- Table 5: Global Diabetes Care Devices Market Revenue Billion Forecast, by Product 2019 & 2032
- Table 6: Global Diabetes Care Devices Market Revenue Billion Forecast, by End-use 2019 & 2032
- Table 7: Global Diabetes Care Devices Market Revenue Billion Forecast, by Country 2019 & 2032
- Table 8: U.S. Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 9: Canada Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 10: Global Diabetes Care Devices Market Revenue Billion Forecast, by Product 2019 & 2032
- Table 11: Global Diabetes Care Devices Market Revenue Billion Forecast, by End-use 2019 & 2032
- Table 12: Global Diabetes Care Devices Market Revenue Billion Forecast, by Country 2019 & 2032
- Table 13: Germany Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 14: UK Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 15: France Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 16: Netherlands Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 17: Sweden Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 18: Belgium Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 19: Denmark Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 20: Finland Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 21: Norway Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 22: Lithuania Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 23: Latvia Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 24: Estonia Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 25: Rest of Europe Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 26: Global Diabetes Care Devices Market Revenue Billion Forecast, by Product 2019 & 2032
- Table 27: Global Diabetes Care Devices Market Revenue Billion Forecast, by End-use 2019 & 2032
- Table 28: Global Diabetes Care Devices Market Revenue Billion Forecast, by Country 2019 & 2032
- Table 29: Japan Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 30: China Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 31: India Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 32: Australia Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 33: South Korea Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 34: Rest of Asia Pacific Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 35: Global Diabetes Care Devices Market Revenue Billion Forecast, by Product 2019 & 2032
- Table 36: Global Diabetes Care Devices Market Revenue Billion Forecast, by End-use 2019 & 2032
- Table 37: Global Diabetes Care Devices Market Revenue Billion Forecast, by Country 2019 & 2032
- Table 38: Brazil Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 39: Mexico Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 40: Argentina Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 41: Colombia Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 42: Chile Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 43: Peru Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 44: Rest of Latin America Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 45: Global Diabetes Care Devices Market Revenue Billion Forecast, by Product 2019 & 2032
- Table 46: Global Diabetes Care Devices Market Revenue Billion Forecast, by End-use 2019 & 2032
- Table 47: Global Diabetes Care Devices Market Revenue Billion Forecast, by Country 2019 & 2032
- Table 48: South Africa Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 49: Saudi Arabia Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 50: UAE Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 51: Turkey Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 52: Egypt Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 53: Israel Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 54: Kuwait Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 55: Qatar Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
- Table 56: Rest of Middle East and Africa Diabetes Care Devices Market Revenue (Billion) Forecast, by Application 2019 & 2032
STEP 1 - Identification of Relevant Samples Size from Population Database
STEP 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segemnts, product and application.
Note* : In applicable scenarios
STEP 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
STEP 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
Additionally after gathering mix and scattered data from wide range of sources, data is triangull- ated and correlated to come up with estimated figures which are further validated through primary mediums, or industry experts, opinion leader.
Frequently Asked Questions
2. Which companies are prominent players in the Diabetes Care Devices Market?
Key companies in the market include Abbott Laboratories, Arkray, Inc., Ascensia Diabetes Care Holding AG, B. Braun Melsungen AG, Becton Dickinson and Company, Bionime Corporation, DarioHealth Corp., Dexcom, Inc., Dr. Reddy's Laboratories, Eli Lilly and Company, F. Hoffmann-La Roche AG, Insulet Corporation, LifeScan, Inc., Medtronic plc, Nova Biomedical, Inc., Novo Nordisk A/S, Pendiq GmBH, Sanofi, Sinocare, Inc., Tandem Diabetes Care Inc., Ypsomed AG.
3. What are the main segments of the Diabetes Care Devices Market?
The market segments include Product, End-use.
4. Can you provide details about the market size?
The market size is estimated to be USD 46.1 Billion as of 2022.
5. What are some drivers contributing to market growth?
Growing prevalence of diabetes across the world. Rising technological advancements in diabetes care devices. Increasing investments by public and private organizations for diabetes care.
6. What are the notable trends driving market growth?
N/A
7. Are there any restraints impacting market growth?
High cost of diabetes care devices. Rigorous regulatory framework.
8. Can you provide examples of recent developments in the market?
In June 2022, Ascensia Diabetes Care received CE Mark approval for its Eversense E3 Continuous Glucose Monitoring (CGM) System for use in European Union (EU) countries. This approval helped the company to extend its market share especially in European countries.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4,850, USD 5,350, and USD 8,350 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Billion.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Diabetes Care Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Diabetes Care Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Diabetes Care Devices Market?
To stay informed about further developments, trends, and reports in the Diabetes Care Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
